Jimini, an AI-backed mental health startup based in New York, has successfully raised $8 million in pre-seed funding. The platform, which aims to revolutionize mental health therapy, pairs patients with licensed clinicians while incorporating an AI assistant called Sage to enhance the therapeutic process.
How Jimini Works
Jimini’s innovative approach starts before the patient’s first therapy session. The AI assistant, Sage, engages with the patient to gather essential information, ensuring that the therapist has relevant context for the initial session. Once this preparatory work is complete, the assigned therapist reaches out to the patient through a personalized video message, introducing themselves and setting the stage for the first virtual therapy session.
After the session, patients receive a recap of their goals, and they can continue interacting with their therapist via a messaging feature. Additionally, Sage remains available to provide further support, offering supplementary activities and tracking progress.
This combination of human expertise and AI-driven assistance is designed to provide a comprehensive, goal-specific care plan for each patient, with continuous oversight from the assigned therapist. Jimini’s founders emphasize that this clinical integration ensures the AI tool is safely and effectively integrated into the therapeutic process.
Key Differentiators
According to Luis Voloch, CEO and co-founder of Jimini Health, the platform stands out from other AI-based therapy tools. He explained, “Jimini is the only AI-augmented therapy experience, with clinically integrated AI that works synergistically with the therapist to drive more value to the patient than either could on their own.”
Unlike many general-purpose chatbots, Sage is specifically designed to help patients meet their therapeutic goals. The platform also focuses on maintaining proper safety protocols and escalation methods, ensuring a higher standard of care than less-regulated alternatives.
Investor Support
The $8 million pre-seed round saw participation from a variety of investors, including Zetta Venture Partners, LionBird, PsyMed, BoxGroup, Arkitekt Ventures, and SCB. David Feinberg, advisor to Jimini Health and chairman at Oracle Health, praised the potential of combining AI with clinicians to improve therapy outcomes, stating, “The Jimini team is doing just that.”
Care Offerings and Pricing
Jimini’s platform provides care for patients dealing with conditions such as anxiety, depression, OCD, grief, postpartum depression, panic disorder, and PTSD. The service starts at $200 per session, with the added benefits of unlimited messaging with therapists throughout the week and access to AI-assisted support.
Industry Context
The mental health technology space has seen fluctuating investment trends, especially since digital behavioral health funding peaked in 2021 and 2022. However, there has been a continued flow of new capital into innovative startups. For instance, in April, hybrid mental health company Two Chairs raised $72 million in Series C funding, and virtual substance use disorder provider Pelago secured $58 million in Series C funding in March.
Jimini’s latest funding success highlights the growing interest in AI-assisted therapy tools that aim to enhance accessibility and effectiveness in mental health care.
Related topics:
